ITMI20061672A1 - Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita' - Google Patents

Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'

Info

Publication number
ITMI20061672A1
ITMI20061672A1 IT001672A ITMI20061672A ITMI20061672A1 IT MI20061672 A1 ITMI20061672 A1 IT MI20061672A1 IT 001672 A IT001672 A IT 001672A IT MI20061672 A ITMI20061672 A IT MI20061672A IT MI20061672 A1 ITMI20061672 A1 IT MI20061672A1
Authority
IT
Italy
Prior art keywords
formulations
derivatives
high stability
soft capsules
acetylsalicylic acid
Prior art date
Application number
IT001672A
Other languages
English (en)
Inventor
Angel Mateo Echanagorria
Maurizio Marchiorri
Giorgio Zoppetti
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Priority to IT001672A priority Critical patent/ITMI20061672A1/it
Priority to PCT/EP2007/059047 priority patent/WO2008025819A2/en
Priority to EP07803056A priority patent/EP2066330A2/en
Priority to CN2007800324526A priority patent/CN101511370B/zh
Priority to CA002662178A priority patent/CA2662178A1/en
Priority to JP2009526105A priority patent/JP2010501632A/ja
Priority to US12/310,634 priority patent/US20100178335A1/en
Publication of ITMI20061672A1 publication Critical patent/ITMI20061672A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
IT001672A 2006-09-01 2006-09-01 Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita' ITMI20061672A1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT001672A ITMI20061672A1 (it) 2006-09-01 2006-09-01 Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'
PCT/EP2007/059047 WO2008025819A2 (en) 2006-09-01 2007-08-30 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability
EP07803056A EP2066330A2 (en) 2006-09-01 2007-08-30 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability
CN2007800324526A CN101511370B (zh) 2006-09-01 2007-08-30 高稳定性的乙酰水杨酸或其衍生物的软胶囊制剂
CA002662178A CA2662178A1 (en) 2006-09-01 2007-08-30 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability
JP2009526105A JP2010501632A (ja) 2006-09-01 2007-08-30 高安定性を示すソフトカプセルにおけるアセチルサリチル酸又はその誘導体の製剤
US12/310,634 US20100178335A1 (en) 2006-09-01 2007-08-30 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001672A ITMI20061672A1 (it) 2006-09-01 2006-09-01 Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'

Publications (1)

Publication Number Publication Date
ITMI20061672A1 true ITMI20061672A1 (it) 2008-03-02

Family

ID=39012151

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001672A ITMI20061672A1 (it) 2006-09-01 2006-09-01 Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'

Country Status (7)

Country Link
US (1) US20100178335A1 (it)
EP (1) EP2066330A2 (it)
JP (1) JP2010501632A (it)
CN (1) CN101511370B (it)
CA (1) CA2662178A1 (it)
IT (1) ITMI20061672A1 (it)
WO (1) WO2008025819A2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013000703A (es) * 2010-07-19 2014-07-24 Procaps Sa Aparato y proceso para encapsular capsulas u otras formas de dosificacion solidas dentro de capsulas.
ES2389348B1 (es) * 2011-04-05 2013-09-23 Simbec Ibérica Sl Polvo compuesto de triflusal, uso del mismo para granulados, comprimidos o sobres, procedimiento para la preparación de dicho polvo compuesto y uso de una o mas ciclodextrinas para estabilizar el triflusal.
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
JP5876695B2 (ja) * 2011-09-29 2016-03-02 森下仁丹株式会社 シームレスカプセルおよびその製造方法
WO2013072767A1 (en) 2011-11-18 2013-05-23 Pronova Biopharma Norge As Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
ITMI20112221A1 (it) 2011-12-05 2013-06-06 Altergon Sa Formulazioni stabili in capsule di gelatina molle di antiaggreganti piastrinici, acidi grassi omega-3 e amilosio
US8673325B1 (en) * 2012-09-06 2014-03-18 Dignity Sciences Limited Cosmetic compositions comprising EPA and salicylic acid and methods of making and using same
JP6018712B2 (ja) * 2014-04-25 2016-11-02 株式会社山田養蜂場本社 不飽和脂肪酸の吸収促進剤
CN111040256A (zh) * 2014-09-19 2020-04-21 江苏崇尚生物科技有限公司 制备淀粉基质空心胶囊的原料组合物及淀粉基质空心胶囊
IT201700015145A1 (it) * 2017-02-10 2018-08-10 Altergon Sa Capsule di gelatina molle ad elevata stabilità
WO2021011538A1 (en) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Capsule dosage forms, methods of preparation and methods of use thereof
WO2021195319A1 (en) 2020-03-26 2021-09-30 Plx Opco Inc. PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND- METHODS FOR MAKING AND USING SAME

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813541A (ja) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物
JPS59190916A (ja) * 1983-04-14 1984-10-29 Morishita Jintan Kk 親水性物質含有軟カプセル
DE3337802A1 (de) * 1983-10-18 1985-04-25 Merck Patent Gmbh, 6100 Darmstadt Pharmazeutische zubereitung
JPS62249920A (ja) * 1986-04-18 1987-10-30 Toyo Kapuseru Kk 光感受性医薬品用のゼラチンカプセル製剤
JPS62249935A (ja) * 1986-04-18 1987-10-30 Toyo Kapuseru Kk サイクロデキストリンを含有する製剤用のゼラチン基質
IT1243192B (it) * 1990-08-09 1994-05-24 Staroil Ltd Complessi di acidi grassi polinsaturi a lunga catena e di loro derivati, con ciclodestrine
ITMI20020731A1 (it) * 2002-04-08 2003-10-08 Ibsa Inst Biochimique Sa Composizioni farmaceutiche per acido acetilsalicilico e oli omega-3
EP1599186B1 (en) * 2003-02-24 2013-04-10 Pharmaceutical Productions Inc. Transmucosal drug delivery system
JP2006056789A (ja) * 2004-08-17 2006-03-02 Oyo Seikagaku Kenkyusho カプセル皮膜組成物
ITMI20050387A1 (it) * 2005-03-11 2006-09-12 Altergon Sa Nuove capsule di gelatina molle

Also Published As

Publication number Publication date
WO2008025819A2 (en) 2008-03-06
CA2662178A1 (en) 2008-03-06
CN101511370B (zh) 2013-01-23
JP2010501632A (ja) 2010-01-21
CN101511370A (zh) 2009-08-19
EP2066330A2 (en) 2009-06-10
WO2008025819A3 (en) 2008-05-08
US20100178335A1 (en) 2010-07-15

Similar Documents

Publication Publication Date Title
ITMI20061672A1 (it) Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita'
FR22C1027I1 (fr) Formulations stabilisant et inhibant la précipitation de compositions immunogènes
NO345139B1 (no) Florizinanaloger som inhibitorer av glukosekotransportør 2 og farmasøytisk sammensetning derav
BRPI0810439A2 (pt) Formulações farmacêuticas contendo derivados de ácido lipóico
CR10229A (es) Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
DK3421471T3 (da) Purin- og deazapurinderivater som farmaceutiske forbindelser
DK2024352T3 (da) Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
DK3150198T3 (da) Farmaceutiske sammensætninger af 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioxol-5-yl)-cyclopropancarboxamido)-3-methylpyriodin-2-yl)benzoesyre og indgivelse deraf
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
IL187957A0 (en) Liquid pharmaceutical formulations of docetaxel
DK2068822T4 (da) Selvpræserverede vandige farmaceutiske sammensætninger
ITPD20050242A1 (it) Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
IT1362675B (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
ITMI20072416A1 (it) Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
CR10665A (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
IL211946A (en) Annotated (2-Hydroxy-2-Phenyl-1-Pyrrolidine-1-Illmethyl-Ethyl) -Carbamic Acid Phenyl Ester
IL198513A0 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
ECSP11011555A (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas
ITPD20050056A1 (it) Derivati ammidici del'acido ialuronico in osteoartrosi
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CR10953A (es) Nuevos derivados triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ITFI20050041A1 (it) Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
ITRM20080214A1 (it) Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico.